Viewing nowNebilet M Tablet 5 mg (Nebivolol Hydrochloride)
Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

MFDS item code 202006680 · Approved 2020.09.28
Essential hypertension, adjunctive treatment of chronic stable heart failure in patients aged 70 years and older
This medication is used as an adjunct to existing standard treatment in patients with essential hypertension and mild to moderate chronic stable heart failure in individuals aged 70 and older. It helps in controlling blood pressure and alleviating heart failure symptoms, thereby improving the patient's condition.
1. Essential hypertension (1) Adults Administer nebivolol 5mg orally once daily at the same time each day. The blood pressure-lowering effect usually becomes apparent after 1~2 weeks of treatment, but may take 4 weeks in some cases. It may be taken with food. (2) Patients with renal impairment The initial dose is nebivolol 2.5mg orally once daily. If necessary, the daily dose may be increased to 5mg. (3) Elderly patients The initial dose in patients aged 65 years or older is nebivolol 2.5mg once daily. If necessary, the daily dose may be increased to 5mg. There is insufficient clinical experience in patients aged 75 years or older; administer with careful monitoring. 2. Chronic heart failure (1) Elderly patients aged 70 years or older This medicine should be administered to patients with chronic stable heart failure who have had no history of acute heart failure during the past 6 weeks. The doses of cardiovascular medicines such as diuretics, digoxin, ACE inhibitors, and angiotensin II receptor blockers should have been stabilized by 2 weeks before starting this medicine. The dose should be gradually increased at 1~2-week intervals, taking the patient's condition into account, until the optimal dose for each patient is reached. Treatment should be initiated with nebivolol 1.25mg once daily and, if necessary, increased to 2.5 mg once daily, 5 mg once daily, and up to 10 mg once daily. The maximum daily dose is 10 mg. It may be taken with food. (2) Patients with renal impairment Because titration to the maximum tolerated dose is adjusted for each patient, no dosage adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment (serum creatinine ≥ 250 μmol/L), as there is no experience with its use in these patients.
This medication should not be used in patients with specific conditions. For instance, it is contraindicated in patients who are allergic to this drug, have respiratory conditions like bronchial asthma, have an excessively slow heart rate, or have acute heart failure. Additionally, it is not recommended for pregnant or breastfeeding women, or patients with severe liver or kidney dysfunction. Patients with genetic issues like lactose intolerance should also avoid taking this medication. Patients with chronic pulmonary diseases, untreated heart failure, diabetes, or elderly individuals should use this drug cautiously and consult a doctor before taking it. During treatment with this medication, side effects such as headaches, dizziness, dyspepsia, shortness of breath, and skin rashes may occur, and if symptoms worsen, immediate consultation with healthcare professionals is recommended. Patients scheduled for surgery should discontinue the use of this drug at least 24 hours prior, and dosage adjustment may be necessary if bradycardia or symptoms of hypotension occur. This drug may interact with other medications, particularly calcium channel blockers, antiarrhythmics, central nervous system medications, and diabetes medications, so caution is advised when taking it with these drugs. Women who are pregnant or may become pregnant, as well as breastfeeding women, should not take this medication, and it is not recommended for children due to safety concerns. Elderly individuals should start with a low dose and closely monitor conditions, as overdose may lead to severe cardiac and respiratory problems, necessitating immediate treatment.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering. The recommended storage temperature is at room temperature between 1°C and 30°C.
White round tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowNebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Chodang Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Aju Pharmaceuticals Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Ellison Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 2.725mg
Tablet · Prescription medication
Erison Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.